Drawing for BIOMEDPHARMIS

USPTO serial 78775461

BIOMEDPHARMIS

Reviewed by CopyMark Law Group

Reg. 3260264Status 710
Filing date
Status date
Registration date
Jul 10, 2007
Examiner
FRYE, KIMBERLY
Law office
TMO LAW OFFICE 113

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BIOMEDPHARMIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer M. Hetu

Jennifer M. Hetu Honigman Miller Schwartz and Cohn LLP39400 Woodward Avenue, Suite 101Bloomfield Hills, MI 48304UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business information and research services in the pharmaceutical and life sciences fields, namely, analysis and creation of customized reports in the fields of pharmaceutical and medical product licensing, creation of consumer product databases, competitor profiles, and the pharmaceutical industrySECTION 8 - CANCELLEDFeb 1, 2004
042Information and research services in the pharmaceutical and life sciences fields, namely, analysis and creation of customized reports in the fields of pharmaceutical and medical product development, pharmaceutical regulatory requirements, clinical trials[, and patent licensing]SECTION 8 - CANCELLEDFeb 1, 2004

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 16, 2018CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jul 10, 2016REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jul 15, 2013CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 15, 2013COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 11, 2013NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 11, 2013C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 11, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 25, 2013E815TEAS SECTION 8 & 15 RECEIVED—
Mar 10, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 10, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 24, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 4, 2007NPUBNOTICE OF PUBLICATION—
Mar 2, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 28, 2007ALIEASSIGNED TO LIE—
Jan 25, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Jan 25, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 25, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 25, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Jan 25, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 25, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 16, 2006GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 2006DOCKASSIGNED TO EXAMINER—
Dec 22, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance